Professor of Surgery and Critical Care Medicine
Louis H. Alarcon, MD, FACS, FCCM is Professor in the Departments of Surgery and Critical Care Medicine at the University of Pittsburgh School of Medicine. Dr. Alarcon is the Medical Director of Trauma Surgery at UPMC-Presbyterian Hospital, Co-Director of the UPMC Patient Blood Management Program, and Director of the Enteral Access Team.
Dr. Alarcon graduated from Grove City College with a Bachelors of Science degree. Dr. Alarcon subsequently obtained his medical degree from the University of Pittsburgh School of Medicine where he was junior AOA. Dr. Alarcon continued at the University of Pittsburgh for surgical residency, research fellowship and surgical critical care fellowship. Alarcon is a diplomate of the American Board of Surgery in Surgery and Surgical Critical Care. As a faculty member he was honored with a Faculty Recognition award from the graduating medical students of the University of Pittsburgh.
Alarcon is a Fellow of the American College of Surgeons, Fellow of the American College of Critical Care Medicine, Fellow of the American Association for the Surgery of Trauma, a member of the Eastern Association for the Surgery of Trauma, the Panamerican Trauma Society, and the Society of Critical Care Medicine.
Dr. Alarcon’s clinical research interests involve the treatment of critically injured patients, specifically in resuscitation, the management of solid organ injury, and prevention and treatment of the coagulopathy of trauma. In addition, he is active in Patient and Family Centered Care initiatives and a number of Quality Improvement projects, including VTE prophylaxis in multiply-injured patients, developing evidenced-based patient care guidelines, and screening for post-traumatic stress disorder in trauma patients. He has co-authored a number of peer-reviewed articles in the journals Surgery, the Journal of Trauma, and American Surgeon. He has co-authored several book chapters, including contributions to Schwartz’s Principles of Surgery, Sabiston’s Textbook of Surgery, and the Textbook of Critical Care. Dr. Alarcon has been the principal investigator (PI) for a number of projects, studying the safety and efficacy of a prothrombin concentrate complex for the reversal of vitamin K antagonist therapy in patients who require urgent surgery or invasive procedures. He is also the co-PI for the Prospective Observational Multicenter Massive Transfusion sTudy (PROMMTT), sponsored by the U.S. Department of Defense, Army Institute of Surgical Research. He is the editor of Trauma Rounds, a publication of the Trauma Division at UPMC. He has been an invited lecturer both nationally and internationally, including at the Panamerican Trauma Society meetings in Lima, Peru and Cartagena, Colombia.
Education & Training
|Universidad Cayetano Heredia, Lima, Peru||1984-86||Biomedical studies|
|Grove City College, Grove City, PA||BS||1986-88||Biology|
|University of Pittsburgh School of Medicine||MD||1988-92||Medicine|
Medical Director, Division of Trauma Surgery
Co-Director of the UPMC Patient Blood Management Program
Director of the Enteral Access Team
|1986-88||National Biologic Honor Society|
|1988||Scroll and Key Honor Society|
|1988||Highest Honors in Biology|
|1988||Undergraduate: graduated Magna Cum Laude|
|1988-92||Boale, Boucek and Hausknecht scholarships|
|1989-92||Joseph Collins Fellowship|
|1991||Alpha Omega Alpha, Junior year, vice-president|
|1992||Eli Goldstein, MD Award for highest academic honors|
|1992||Dr. Richard J. Behan Prize in Surgery|
|1992||Pittsburgh Surgical Society Scholarship Award|
|1992||Medical School: graduated Cum Laude|
|1996||Davis & Geck Resident Research Award|
|1997-99||American College of Surgeons Resident Research Scholarship|
|2005||Faculty Recognition Award|
|2005||Fellow of the American College of Surgeons|
|2015||Fellow of the American College of Critical Care Medicine|
PRospective, Observational, Multi-center Massive Transfusion sTudy (PROMMTT) (U.S. Department of Defense, Army Institute of Surgical Research).
A randomized, open-label, efficacy and safety study of Octaplex and fresh frozen plasma (FFP) in patients under vitamin K antagonist therapy with the need for urgent surgery or invasive procedures (Octapharma)